Dr. Spyropoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-273-5573
Education & Training
University of New Mexico School of MedicineResidency, Internal Medicine, 1992 - 1995
Perelman School of Medicine at the University of PennsylvaniaClass of 1992
Certifications & Licensure
NY State Medical License 2011 - 2025
NM State Medical License 1993 - 2024- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2001
Clinical Trials
Publications & Presentations
PubMed
- Universal clinical decision support tool for thromboprophylaxis in hospitalized COVID-19 patients: post hoc analysis of the IMPROVE-DD cluster randomized trial.Mark Goldin, Nikolaos Tsaftaridis, Ioannis Koulas, Jeffrey Solomon, Michael Qiu
Journal of Thrombosis and Haemostasis. 2024-11-01 - Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcom...Neil A Goldenberg, Sam Schulman, John M Kittelson, Thomas C Abshire, James F Casella
Journal of Thrombosis and Haemostasis. 2024-10-24 - 1 citationsPerioperative Management of Patients Taking Direct Oral Anticoagulants: A Review.James D Douketis, Alex C Spyropoulos
JAMA. 2024-09-10
Journal Articles
- Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized AnticoagulationAlex C Spyropoulos, Craig M Kessler, Bhavi Pandya, Seminars in Thrombosis and Hemostasis
Abstracts/Posters
- Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) StudyAlex Spyropoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magell...Alex C. Spyropoulo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
Feinstein Institutes Research Suggests New Management Protocols for Patients Taking Oral AnticoagulantsSeptember 11th, 2024- When to Stop DOAC Before Urologic SurgeryAugust 26th, 2024
- COVID-19 Patients with Cardiovascular Disease More Likely to Develop Blood Clots Post-Hospital Discharge, Feinstein Institutes StudyMay 23rd, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
